Al-Dawaa Medical Services Company (4163.SR)
- Previous Close
89.30 - Open
89.50 - Bid 91.50 x --
- Ask 91.70 x --
- Day's Range
88.60 - 91.60 - 52 Week Range
77.30 - 121.60 - Volume
227,700 - Avg. Volume
200,731 - Market Cap (intraday)
7.786B - Beta (5Y Monthly) 0.02
- PE Ratio (TTM)
23.67 - EPS (TTM)
3.87 - Earnings Date --
- Forward Dividend & Yield 2.50 (2.73%)
- Ex-Dividend Date Feb 13, 2024
- 1y Target Est
116.90
Al-Dawaa Medical Services Company, together with its subsidiaries, primarily operates as a pharmaceutical retail company in the Kingdom of Saudi Arabia. It operates through three segments: Retail, Wholesale, and Logistics. The company offers medicines, perfumes, cosmetics, beauty tools and products, and other pharmaceutical products. It is also involved in pharmacy activities, pharmaceutical warehousing activities, retailing of medical and other equipment, land transport of goods, managing and renting self-storage stores, and provision of marketing services on behalf of third parties, as well as acting as a pharmaceutical agent. The company sells its pharmaceutical products through a network of pharmacies, as well as online and wholesale channels. Further, it engages in the manufacture of single-use medical products, consumables, medical examination tables, surgical furniture, beds with mechanical motion additives, medical thermometers, respirators, and medical anesthesia solutions; granting marketing licenses for pharmaceutical products, consumer goods, and food products; and provision of health care management consulting, as well as delivery services via electronic platforms. The company was founded in 1993 and is based in Khobar, the Kingdom of Saudi Arabia.
www.al-dawaa.com.sa--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 4163.SR
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4163.SR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4163.SR
Valuation Measures
Market Cap
7.79B
Enterprise Value
10.03B
Trailing P/E
23.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.36
Price/Book (mrq)
5.93
Enterprise Value/Revenue
1.75
Enterprise Value/EBITDA
12.07
Financial Highlights
Profitability and Income Statement
Profit Margin
5.73%
Return on Assets (ttm)
6.37%
Return on Equity (ttm)
27.34%
Revenue (ttm)
5.74B
Net Income Avi to Common (ttm)
329.22M
Diluted EPS (ttm)
3.87
Balance Sheet and Cash Flow
Total Cash (mrq)
54.32M
Total Debt/Equity (mrq)
174.73%
Levered Free Cash Flow (ttm)
367.04M
Research Analysis: 4163.SR
Analyst Price Targets
Fair Value
No Fair Value available for this ticker
Company Insights: 4163.SR
4163.SR does not have Company Insights